FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称REVUMENIB SESQUIFUMARATE
异名/同义词BENZAMIDE, N-ETHYL-2-((4-(7-((TRANS-4-((ETHYLSULFONYL)AMINO)CYCLOHEXYL)METHYL)-2,7-DIAZASPIRO(3.5)NON-2-YL)-5-PYRIMIDINYL)OXY)-5-FLUORO-N-(1-METHYLETHYL)-, (2E)-2-BUTENEDIOATE (2:3)
REVUMENIB SESQUIFUMARATE
SNDX 5613 [WHO-DD]
SNDX50613
SNDX-50613
SNDX5613
SNDX-5613
CAS登记号2169919-22-4
物质唯一标识(Unique Ingredient Identifier)75HI05N8HS
分子式2C32H47FN6O4S.3C4H4O4
国际化合物标识(International Chemical Identifier,InChI)AXNUWYROYVRYIM-OQIJCFCCSA-N
SMILESc1c(ccc(c1C(N(CC)C(C)C)=O)Oc2c(ncnc2)N3CC4(C3)CCN(CC4)C[C@@H]5CC[C@H](CC5)NS(CC)(=O)=O)F.OC(/C=C/C(O)=O)=O.c1c(ccc(c1C(N(CC)C(C)C)=O)Oc2c(ncnc2)N3CC4(C3)CCN(CC4)C[C@@H]5CC[C@H](CC5)NS(CC)(=O)=O)F.OC(/C=C/C(O)=O)=O.OC(/C=C/C(O)=O)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System